A Quantitative MR Study of the Hippocampal Formation, the Amygdala, and the Temporal Horn of the Lateral Ventricle in Healthy Subjects 40 to 90 Years of Age

References

1. ↵
   Goate A, Chartier-Harlin MC, Mullan ME, et al. Segregation of a missense mutation in the amygdala precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-706

   CrossRefPubMedWeb of Science
2. ↵
   Scott J. Apolipoprotein E and Alzheimer's disease. Lancet 1993;342:696-699

   CrossRefPubMedWeb of Science
3. Hauw JJ, Duyckaerts C, Delaere P. Neuropathology of aging and SDAT: how can age related changes be distinguished from those due to disease process? In: Henderson AS, Henderson JH, Bernhard S, eds. Dahlem konferenzen, Etiology of dementia of Alzheimer type Chichester: Wiley; 1988;195-211
4. ↵
   Lehericy S, Baulac M, Chiras J, et al. Amygdalahippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol 1994;15:929-937

   Abstract/FREE Full Text
5. Deleon MJ, George AE, Golomb J, et al. Frequency of hippocampal formation atrophy in normal aging and Alzheimer disease. Neurobiol Aging 1997;18:1-11

   CrossRefPubMedWeb of Science
6. Freeborough PA, Fox NC, Kitney RI. Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput Methods Programs Biomed 1997;53:15-25

   CrossRefPubMedWeb of Science
7. Kaye JA, Swihaart T, Howieson D, et al. Volume loss of the hippocampus and temporal lobe in healthy persons destined to develop dementia. Neurology 1997;40:1297-1304
8. Fox NC, Warrington EK, Freeborogh PA, et al. Presymptomatic hippocampal atrophy in Alzheimer disease: a longitudinal MRI study. Brain 1996;119:2001-2004

   Abstract/FREE Full Text
9. ↵
   Jack CR Jr, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997;49:786-794

   Abstract/FREE Full Text
10. ↵
    Hachinski VC, Iliff LD, Kihika et al. Cerebral flow in dementia. Arch Neurol 1975;32:632-637

    CrossRefPubMedWeb of Science
11. ↵
    Reisberg B, Ferris SH, Deleon MJ, Crook T. The Global Deterioration Scale (GDS): an instrument for the assessment of primary degenerative dementia (PDD). Am J Psychiatry 1982;139:1136-1139

    PubMedWeb of Science
12. Kesslack JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 1991;41:51-54

    Abstract/FREE Full Text
13. Jack CR Jr, Petersen RC, O'Brien PC, et al. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188

    Abstract/FREE Full Text
14. Seab JP, Jagust WJ, Wong STS, et al. Quantitative MR measurements of hippocampal atrophy in Alzheimer's disease. Magn Reson Med 1988;8:200-208

    PubMedWeb of Science
15. ↵
    Pearson RCA, Esiri MM, Hiorns RW, et al. Anatomical correlates of the distribution of the pathology changes in the neocortex in AD. Proc Natl Acad Sci U S A 1985;82:4531-4534

    Abstract/FREE Full Text
16. Naidich TP, Daniels DL, Haughton VM, et al. Hippocampal formation and related structures of the limbic lobe: anatomic-MR correlation, 1: surface features and coronal sections. Radiology 1987;162:747-754

    PubMedWeb of Science
17. Watson C, Andermann F, Gloor P, et al. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology 1992;42:1743-1750

    Abstract/FREE Full Text
18. ↵
    Nieuwenhuys R, Voogd J, Van Huijzen Chr. The Human Central Nervous System, a Synopsis and Atlas. 3rd ed. Berlin: Springer; 1988
19. ↵
    Duvernoy HM. The Human Hippocampus: An Atlas of Applied Anatomy. Munich: Bergmann; 1988
20. ↵
    Mckhann G, Drachman D, Folstein M, et al. Clinical diagnosis of AD disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on AD Disease. Neurology 1984;34:939-944

    Abstract/FREE Full Text